Liebrich Markus, Charitos Efstratios, Stadler Charlotte, Roser Detlef, Merk Denis R, Doll Nicolas, Hemmer Wolfgang, Voth Vladimir
Department of Cardiac Surgery, Sana Cardiac Surgery, Stuttgart, Germany.
Department of Cardiac Surgery, University Hospital, Bonn, Germany.
Eur J Cardiothorac Surg. 2020 Nov 1;58(5):1072-1079. doi: 10.1093/ejcts/ezaa149.
The aim of this study was to evaluate whether additional cusp interventions and valve types affect aortic valve-related reoperation and mortality rates after the David procedure.
Between 1997 and 2018, a total of 449 patients {372 males; mean age 54.2 [standard deviation (SD) 15.2] years, range: 12.7-79.9 years} underwent elective valve-sparing aortic root replacement (David procedure) for aortic regurgitation and were prospectively followed up clinically and echocardiographically.
The follow-up was 94% complete. Cumulative follow-up time was 2268 patient-years [mean follow-up time 5.1 (4.3 SD) years]. Thirty-day mortality was 2.2% (n = 10). Late (>30 days) survival did not differ from that of the age- and gender-matched general population. Freedom from reoperation in patients without additional cusp reconstruction was 94% [95% confidence interval (CI) 91-98] and 92% (95% CI 88-97) at 5 and 10 years, respectively, which was not significantly different (P = 1) for patients who did require additional cusp reconstruction 98% (95% CI 95-100) and 89% (95% CI 81-99). In patients with tricuspid aortic valves (n = 338), freedom from reoperation was 96% (95% CI 94-99) and 93% (95% CI 88-97) at 5 and 10 years, respectively. Patients with bicuspid aortic valves (n = 111) had a freedom from reoperation of 94% (95% CI 89-99) at 5 years and 88% (95% CI 79-98) at 10 years (P = 0.021 for the comparison to tricuspid aortic valve). Overall, 23 patients (5%; 1%/patient-year) required reoperation with a mean interval of 4.5 (4.8 SD) months.
The David procedure revealed low mid-term reoperation risk and excellent survival independent of adjunctive cusp interventions/valve morphology and is comparable with that of the age- and gender-matched general population.
本研究旨在评估额外的瓣叶干预措施和瓣膜类型是否会影响大卫手术(David procedure)后主动脉瓣相关再次手术率和死亡率。
1997年至2018年间,共有449例患者(372例男性;平均年龄54.2[标准差(SD)15.2]岁,范围:12.7 - 79.9岁)因主动脉瓣反流接受了择期保留瓣膜主动脉根部置换术(大卫手术),并接受了临床和超声心动图的前瞻性随访。
随访完成率为94%。累积随访时间为2268患者年[平均随访时间5.1(4.3 SD)年]。30天死亡率为2.2%(n = 10)。晚期(>30天)生存率与年龄和性别匹配的普通人群无差异。未进行额外瓣叶重建的患者5年和10年再次手术自由度分别为94%[95%置信区间(CI)91 - 98]和92%(95% CI 88 - 97),对于需要额外瓣叶重建的患者,5年和10年再次手术自由度分别为98%(95% CI 95 - 100)和89%(95% CI 81 - 99),两者差异无统计学意义(P = 1)。在三尖瓣主动脉瓣患者(n = 338)中,5年和10年再次手术自由度分别为96%(95% CI 94 - 99)和93%(95% CI 88 - 97)。二叶式主动脉瓣患者(n = 111)5年和10年再次手术自由度分别为94%(95% CI 89 - 99)和88%(95% CI 79 - 98)(与三尖瓣主动脉瓣比较,P = 0.021)。总体而言,23例患者(5%;1%/患者年)需要再次手术,平均间隔时间为4.5(4.8 SD)个月。
大卫手术显示出中期再次手术风险低,且生存率良好,与辅助瓣叶干预措施/瓣膜形态无关,与年龄和性别匹配的普通人群相当。